Intérêt et limites de la détermination de l’activité enzymatique de l’α-galactosidase A dans les populations à risque pour la maladie de Fabry
Med Sci (Paris), 21 (2005) 53-54
Published online: 2005-11-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
La maladie de Fabry : de la découverte des lysosomes à l’avènement de la thérapeutique
Dominique P. Germainmédecine/sciences 21 5 (2005)
DOI: 10.1051/medsci/20052111s5
See this article
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L van der Tol, B E Smid, B J H M Poorthuis, et al.Journal of Medical Genetics 51 (1) 1 (2014)
DOI: 10.1136/jmedgenet-2013-101857
See this article
The Role of Bile Acid Excretion in Atherosclerotic Coronary Artery Disease
Gideon Charach, Alexander Rabinovich, Ori Argov, Moshe Weintraub and Pavel RabinovichInternational Journal of Vascular Medicine 2012 1 (2012)
DOI: 10.1155/2012/949672
See this article
Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome
Gideon Charach, Ori Argov, Karyn Geiger, et al.Therapeutic Advances in Gastroenterology 11 1756283X1774342 (2018)
DOI: 10.1177/1756283X17743420
See this article